Social Graces

hedgies celebrate at the now-annual Round Hill Club Ozempic party

A friend of mine, old money Greenwich, and intimate with all the proper clubs and organizations in town, recently told me that the new money 30-somethings finance crowd now infesting those same institutions are all on Ozempic and other weight-loss drugs. Not because they’re fat — their basement gyms take care of that — but because it’s the new thing, and one can’t possibly carry on a conversation with one’s peers at social gatherings unless you can knowledgeably discuss the respective merits of Ozempic vs Wegovy or Zepbound.

I was initially skeptical — who would voluntarily inject a drug into his body that sees new, dreadful and deadly side effects reported daily? – but I saw this related story today, and realized that my friend was probably not exaggerating and perhaps even understating the fad now sweeping through what passes for high society.

I ran into an investor friend who was summering in California. He ordered a glass of Santa Barbara pinot and told me: “I didn’t drink for a year. Then on New Year’s I woke up and realized how boring my life had become. So I had a few drinks that day, and suddenly life had color again.”

When I asked why he quit in the first place, the answer was simple: better sleep, fewer distractions, full immersion in work.

He’s the type who goes all in, which is part of what makes him world-class. So when he discovered longevity, he didn’t dabble. He installed a hyperbaric chamber, bought an infrared sauna, and swapped happy hours for tennis matches. A year later, he’d landed on a middle ground. Still disciplined, but now sipping a couple of glasses of wine. Nothing extreme. And he seemed lighter, even happier.

Listening to him explain his new regimen, I realized how far we’d drifted from our twenties. Back then it was shots of top-shelf tequila. Now it’s top-shelf supplements and IV shots of NAD+.

In Los Angeles, status used to mean a G-Wagon in the driveway, a Nobu reservation, a Riviera golf membership, or a Bird Streets house “next to Leo.” That game isn’t gone, but the subtler flex now looks less like Rodeo Drive and more like a medical lab. The question isn’t “What car are you driving?” It’s “What’s your protocol?”

Designer closets have given way to microdosing GLP-1. Hollywood Bowl tickets have been swapped for Hyrox race entries that sell out faster than Coachella.

Bryan Johnson, Andrew Huberman, and Peter Attia are the new A-listers. Nobody’s quoting movies anymore, but everyone’s comparing T levels.

In tech WhatsApp groups, biomarker screenshots now circulate with the same energy Porsche waitlist confirmations once did. Even the biggest celebrities have joined in, turning their “health journeys” into content. In August, the Kardashians flew to Mexico for stem-cell therapy banned in the U.S., a ban that only made it more exclusive. Naturally, it became both an Instagram flex with a million likes and a tabloid headline.

Part of it is just age. My friends are getting older, and the ones with early-adopter instincts—and money—have found a new playground in personalized medicine.

The same people who once hunted obscure apps or underground music are now swapping supplement stacks and sleep hacks.

COVID accelerated it. Locked indoors, people built home gyms, experimented with diets, and turned longevity from a fringe hobby into a mainstream obsession. The old signals also got boring. A Ferrari says money. A cold plunge says enlightenment.